SHANGBAY CAPITAL
Best-in-class investments mainly in the U.S. medical devices technology, as well as biotech, and mobile healthcare sectors through early sta
SHANGBAY CAPITAL
Social Links:
Founded:
2015-01-01
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Euro Google Apps For Business GStatic Google Static Content Sectigo SSL Sectigo Domain SSL
Similar Organizations
1315 Capital
1315 Capital provides expansion and growth capital to commercial stage pharmaceuticals, medical technologies, and healthcare services.
Caruso Ventures
Investing in High-Impact Scaleups, Seismic Trends and Next Generation Entrepreneurial Leaders
Fusion Fund
Fusion Fund invests in early stage companies with technological and data advantages in industrial, enterprise, and healthcare applications.
Susquehanna Growth Equity
Susquehanna Growth Equity invests in growth stage technology companies in the software, information services, and internet.
What If Ventures
What If Ventures invests primarily in mental health, addiction, and stigmatized healthcare services from seed stage to pre-IPO.
Current Advisors List
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-02-07 | Huma.AI | Shangbay Capital investment in Series A - Huma.AI | 9.5 M USD |
| 2021-10-20 | Contraline | Shangbay Capital investment in Series A - Contraline | 10.7 M USD |
| 2021-09-01 | Laplace Interventional | Shangbay Capital investment in Series A - Laplace Interventional | 7.9 M USD |
| 2021-08-11 | Fluid Biomed Inc. | Shangbay Capital investment in Seed Round - Fluid Biomed Inc. | 4.7 M USD |
| 2021-07-27 | Neuro42 | Shangbay Capital investment in Series A - Neuro42 | 6.5 M USD |
| 2021-07-27 | IgGenix | Shangbay Capital investment in Series A - IgGenix | 25 M USD |
| 2021-05-25 | Emboline | Shangbay Capital investment in Series D - Emboline | 55 M USD |
| 2021-03-22 | EpimAb Biotherapeutics | Shangbay Capital investment in Series C - EpimAb Biotherapeutics | 120 M USD |
| 2021-01-27 | SetPoint Medical | Shangbay Capital investment in Venture Round - SetPoint Medical | 64 M USD |
| 2020-09-01 | Aqua Medical | Shangbay Capital investment in Series A - Aqua Medical | 8.2 M USD |